AS
Andromeda Surgical
United States · Robotics
Andromeda Surgical develops autonomous surgical robots combining anatomical mapping and surgeon oversight, initially for prostate enucleation.
Surgical robotics for urology
Andromeda Surgical develops an autonomous robotic surgery platform, beginning with holmium laser enucleation of the prostate, or HoLEP. The procedure treats an enlarged prostate, and the company aims to make it easier for urologists to perform through robotic assistance.
Anatomical mapping and surgeon oversight
The platform combines AI-based anatomical mapping with autonomy under a surgeon’s supervision. A tablet interface supports the workflow. Its development brings software into procedural guidance and decision-making alongside control of instruments.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $15M | Standard Capital — LeadAlumni Ventures Group — ParticipantCybernetix Ventures — ParticipantJSK Investments SICAV a.s. — ParticipantLingotto Innovation — ParticipantNZVC — ParticipantPhaze Ventures — ParticipantRebel Fund — ParticipantTechable VC — ParticipantVox Capital — ParticipantWestWave Capital — ParticipantY Combinator (YC) — ParticipantZelda Ventures — ParticipantZeno Partners — Participant |